Chemotherapy-induced hepatotoxicity

Ameet V. Thatishetty, Nicholas Agresti, Christopher B O'Brien

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Most hepatotoxicity secondary to chemotherapy is idiosyncratic and, therefore, neither dose dependent nor predictable. Some chemotherapy is cleared by the liver and requires dose adjustment in the face of significant liver dysfunction. In addition, preexisting abnormal liver function has been shown to increase the risk of hepatotoxicity. In addition to typical hepatocellular injury, other presentations, including cholestasis and hepatic sinusoidal obstruction syndrome, also commonly occur. The outcomes can range from asymptomatic liver function test abnormalities, which resolve spontaneously, to cirrhosis, which occurs despite discontinuation of the chemotherapeutic agent.

Original languageEnglish
Pages (from-to)671-686
Number of pages16
JournalClinics in Liver Disease
Volume17
Issue number4
DOIs
StatePublished - Nov 1 2013

Fingerprint

Drug Therapy
Liver
Hepatic Veno-Occlusive Disease
Liver Function Tests
Cholestasis
Liver Diseases
Fibrosis
Wounds and Injuries

Keywords

  • Cancer
  • Chemotherapy
  • Drugs
  • Hepatotoxicity
  • Liver

ASJC Scopus subject areas

  • Hepatology

Cite this

Chemotherapy-induced hepatotoxicity. / Thatishetty, Ameet V.; Agresti, Nicholas; O'Brien, Christopher B.

In: Clinics in Liver Disease, Vol. 17, No. 4, 01.11.2013, p. 671-686.

Research output: Contribution to journalArticle

Thatishetty, Ameet V. ; Agresti, Nicholas ; O'Brien, Christopher B. / Chemotherapy-induced hepatotoxicity. In: Clinics in Liver Disease. 2013 ; Vol. 17, No. 4. pp. 671-686.
@article{6e6b699c0c4641c9bd1c3ac5437be8cd,
title = "Chemotherapy-induced hepatotoxicity",
abstract = "Most hepatotoxicity secondary to chemotherapy is idiosyncratic and, therefore, neither dose dependent nor predictable. Some chemotherapy is cleared by the liver and requires dose adjustment in the face of significant liver dysfunction. In addition, preexisting abnormal liver function has been shown to increase the risk of hepatotoxicity. In addition to typical hepatocellular injury, other presentations, including cholestasis and hepatic sinusoidal obstruction syndrome, also commonly occur. The outcomes can range from asymptomatic liver function test abnormalities, which resolve spontaneously, to cirrhosis, which occurs despite discontinuation of the chemotherapeutic agent.",
keywords = "Cancer, Chemotherapy, Drugs, Hepatotoxicity, Liver",
author = "Thatishetty, {Ameet V.} and Nicholas Agresti and O'Brien, {Christopher B}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.cld.2013.07.010",
language = "English",
volume = "17",
pages = "671--686",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Chemotherapy-induced hepatotoxicity

AU - Thatishetty, Ameet V.

AU - Agresti, Nicholas

AU - O'Brien, Christopher B

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Most hepatotoxicity secondary to chemotherapy is idiosyncratic and, therefore, neither dose dependent nor predictable. Some chemotherapy is cleared by the liver and requires dose adjustment in the face of significant liver dysfunction. In addition, preexisting abnormal liver function has been shown to increase the risk of hepatotoxicity. In addition to typical hepatocellular injury, other presentations, including cholestasis and hepatic sinusoidal obstruction syndrome, also commonly occur. The outcomes can range from asymptomatic liver function test abnormalities, which resolve spontaneously, to cirrhosis, which occurs despite discontinuation of the chemotherapeutic agent.

AB - Most hepatotoxicity secondary to chemotherapy is idiosyncratic and, therefore, neither dose dependent nor predictable. Some chemotherapy is cleared by the liver and requires dose adjustment in the face of significant liver dysfunction. In addition, preexisting abnormal liver function has been shown to increase the risk of hepatotoxicity. In addition to typical hepatocellular injury, other presentations, including cholestasis and hepatic sinusoidal obstruction syndrome, also commonly occur. The outcomes can range from asymptomatic liver function test abnormalities, which resolve spontaneously, to cirrhosis, which occurs despite discontinuation of the chemotherapeutic agent.

KW - Cancer

KW - Chemotherapy

KW - Drugs

KW - Hepatotoxicity

KW - Liver

UR - http://www.scopus.com/inward/record.url?scp=84884981466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884981466&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2013.07.010

DO - 10.1016/j.cld.2013.07.010

M3 - Article

VL - 17

SP - 671

EP - 686

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -